Detail
| RLID: | RLID00028806 |
| RNA Symbol: | hsa-miR-92a-3p |
| RNA Category: | miRNA |
| Organism: | Homo sapiens |
| Aliase: | hsa-miR-92, hsa-miR-92a |
| Subcellular Localization: | |
| Localization | Tissue | Validated Method | PMID |
| Circulating | Serum | qRT-PCR | 21098710 |
| Description: By selecting miRNAs that have 3-fold higher expression in HBV compared with control serum, we identified total of 13 upregulated miRNAs, including miR-375, miR-92a, miR-10a, miR-223, miR-423, miR-23b/a, miR-342-3p, miR-99a, miR-122a, miR-125b, miR-150, and let-7c. As shown in Figure 2, the upregulation of these 13 miRNA expressions in the serum of HBV cases, compared with those of controls, was largely consistent when detected by Solexa in pooled samples and qRT-PCR in individual samples. Data are collected from Figure 2. | |||
Other Subcellular Localization:
| RLID | Localization | Tissue | Validated Method | PMID |
| RLID00028803 | Circulating | Serum | qRT-PCR | 18954897 |
| RLID00028804 | Circulating | Serum | Microarray | 19597549 |
| RLID00028805 | Circulating | Plasma | qRT-PCR|Microarray | 20883153 |
| RLID00028807 | Circulating | Plasma | qRT-PCR | 21383985 |
| RLID00028808 | Circulating | serum | qRT-PCR|RNA-seq | 22094284 |
| RLID00028809 | Circulating | Plasma | qRT-PCR | 22262318 |
| RLID00028810 | Circulating | Serum | qRT-PCR | 22798503 |
| RLID00028811 | Circulating | Cerebrospinal fluid | Next-generation sequencing|RT-PCR | 23525801 |
| RLID00028812 | Circulating | Serum | Next-generation sequencing|RT-PCR | 23525801 |
| RLID00028813 | Circulating | Serum | Next-generation sequencing | 23641832 |
| RLID00028814 | Circulating | Follicular fluid | Microarray | 23666971 |
| RLID00028815 | Cytoplasm | Nasopharyngeal carcinoma cell | Next-generation sequencing | 20498841 |
| RLID00028816 | Cytoplasm | HeLa cell | Microarray | 21695135 |
| RLID00028817 | Exosome | Serum | Microarray | 18589210 |
| RLID00028818 | Exosome | Breast cancer cell | Microarray | 20976003 |
| RLID00028819 | Exosome | Dendritic cell | Microarray | 21505438 |
| RLID00028820 | Exosome | B cell | Microarray | 21505438 |
| RLID00028821 | Circulating | Serum | RT-PCR | 22427800 |
| RLID00028822 | Exosome | Brain tissue | Microarray | 23382797 |
| RLID00028823 | Exosome | Plasma | Next-generation sequencing | 23663360 |
| RLID00028824 | Exosome | Esophageal cancer cell | Next-generation sequencing | 25184951 |
| RLID00028825 | Microvesicle | Glioblastoma cell | qRT-PCR|Microarray | 19011622 |
| RLID00028826 | Microvesicle | Plasma | Next-generation sequencing | 23077538 |
| RLID00028827 | Microvesicle | Seminal Plasma | Microarray | 23539611 |
| RLID00028828 | Microvesicle | Follicular fluid | Microarray | 23666971 |
| RLID00028829 | Mitochondrion | Skeletal muscular cell | In situ hybridization|qRT-PCR | 21637849 |
| RLID00028830 | Mitochondrion | HeLa cell | Next-generation sequencing | 22984580 |
| RLID00028831 | Mitochondrion | Eembryonic kidney cell | Next-generation sequencing | 22984580 |
| RLID00028832 | Nucleus | Nasopharyngeal carcinoma cell | Next-generation sequencing | 20498841 |
| RLID00028833 | Nucleolus | HeLa|MCF7 | Microarray | 24918059 |
| RLID00028834 | Exosome | Cerebrospinal fluid | Next-generation sequencing | 25420022 |
| RLID00028835 | Circulating | Serum | RT-PCR | 25165030 |
| RLID00028836 | Circulating | Plasma | Next-generation sequencing | 25415674 |
| RLID00028837 | Exosome | Serum | Next-generation sequencing | 24683445 |
| RLID00028838 | Exosome | Plasma | Next-generation sequencing | 24683445 |
| RLID00028839 | Cytoplasm | HeLa|MCF7 | Microarray | 24918059 |
| RLID00028840 | Nucleus | HeLa|MCF7 | Microarray | 24918059 |
| RLID00028841 | Cytoplasm | Umbilical vein endothelial cell | TEPA-PCL | 24105805 |
| RLID00028842 | Exosome | Renal carcinomas cell | - | 22529849 |
| RLID00028843 | Exosome | Glioblastoma cell | - | 22529849 |
| RLID00028844 | Circulating | Serum | Next-generation sequencing | 22719975 |
| RLID00028845 | Exosome | Mast cell | Microarray | 24009880 |